| Dr Eduardo J Gonzalez Pons, MD | |
|
Calle Hernandez Carrion, Manati, PR 00674 | |
| (866) 808-5771 | |
| Not Available |
| Full Name | Dr Eduardo J Gonzalez Pons |
|---|---|
| Gender | Male |
| Speciality | Interventional Radiology |
| Experience | 17 Years |
| Location | Calle Hernandez Carrion, Manati, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316133978 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Manati Medical Center Dr Otero Lopez | Manati, PR | Hospital |
| Bayamon Medical Center | Bayamon, PR | Hospital |
| Entity Name | San Pablo Developers |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760478549 PECOS PAC ID: 2860451218 Enrollment ID: O20041206000150 |
News Archive
Frequent bouts of depression, anxiety, hostility and anger are known to increase a person's risk for developing coronary heart disease, but a combination of these "negative" personality traits may put people at especially serious risk, according to a study by researchers at Duke University Medical Center.
The FDA today announced that it will open a public docket to begin receiving public comments on the Institute of Medicine's report on the 510(k) program, the most common pathway to market for lower-risk medical devices.
High-dose chemotherapy and autologous stem cell transplantation, the controversial, arduous, yet once-popular combination treatment that fell out of favor as a therapy for breast cancer, has proven not to be beneficial as an adjuvant therapy for women with node-positive disease, according to an expansive analysis conducted by researchers at The University of Texas M. D. Anderson Cancer Center.
The results of a new study revealed that treatment for women with HER2-positive breast cancer – an aggressive form of the disease which is diagnosed in 10,000 British women each year – slowed the progression of tumors by 40 per cent compared with conventional drugs. Tests on 137 women showed that the new therapy – called T-DM1 – which combines the drug Herceptin with an antibody drug, instead of with standard chemotherapy, appeared to stop the cancer "in its tracks".
Astra Tech, a market leader and innovator in the field of implant dentistry and CAD/CAM abutments, announces a global strategic alliance with 3Shape A/S, the Danish-based provider of 3D scanners and CAD/CAM software solutions.
› Verified 3 days ago
| Entity Name | Sm Imaging Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770915894 PECOS PAC ID: 2860620440 Enrollment ID: O20140103000564 |
News Archive
Frequent bouts of depression, anxiety, hostility and anger are known to increase a person's risk for developing coronary heart disease, but a combination of these "negative" personality traits may put people at especially serious risk, according to a study by researchers at Duke University Medical Center.
The FDA today announced that it will open a public docket to begin receiving public comments on the Institute of Medicine's report on the 510(k) program, the most common pathway to market for lower-risk medical devices.
High-dose chemotherapy and autologous stem cell transplantation, the controversial, arduous, yet once-popular combination treatment that fell out of favor as a therapy for breast cancer, has proven not to be beneficial as an adjuvant therapy for women with node-positive disease, according to an expansive analysis conducted by researchers at The University of Texas M. D. Anderson Cancer Center.
The results of a new study revealed that treatment for women with HER2-positive breast cancer – an aggressive form of the disease which is diagnosed in 10,000 British women each year – slowed the progression of tumors by 40 per cent compared with conventional drugs. Tests on 137 women showed that the new therapy – called T-DM1 – which combines the drug Herceptin with an antibody drug, instead of with standard chemotherapy, appeared to stop the cancer "in its tracks".
Astra Tech, a market leader and innovator in the field of implant dentistry and CAD/CAM abutments, announces a global strategic alliance with 3Shape A/S, the Danish-based provider of 3D scanners and CAD/CAM software solutions.
› Verified 3 days ago
| Entity Name | West Coast Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275045874 PECOS PAC ID: 0143583336 Enrollment ID: O20180423001305 |
News Archive
Frequent bouts of depression, anxiety, hostility and anger are known to increase a person's risk for developing coronary heart disease, but a combination of these "negative" personality traits may put people at especially serious risk, according to a study by researchers at Duke University Medical Center.
The FDA today announced that it will open a public docket to begin receiving public comments on the Institute of Medicine's report on the 510(k) program, the most common pathway to market for lower-risk medical devices.
High-dose chemotherapy and autologous stem cell transplantation, the controversial, arduous, yet once-popular combination treatment that fell out of favor as a therapy for breast cancer, has proven not to be beneficial as an adjuvant therapy for women with node-positive disease, according to an expansive analysis conducted by researchers at The University of Texas M. D. Anderson Cancer Center.
The results of a new study revealed that treatment for women with HER2-positive breast cancer – an aggressive form of the disease which is diagnosed in 10,000 British women each year – slowed the progression of tumors by 40 per cent compared with conventional drugs. Tests on 137 women showed that the new therapy – called T-DM1 – which combines the drug Herceptin with an antibody drug, instead of with standard chemotherapy, appeared to stop the cancer "in its tracks".
Astra Tech, a market leader and innovator in the field of implant dentistry and CAD/CAM abutments, announces a global strategic alliance with 3Shape A/S, the Danish-based provider of 3D scanners and CAD/CAM software solutions.
› Verified 3 days ago
| Entity Name | Sm Imaging Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770915894 PECOS PAC ID: 8820425937 Enrollment ID: O20200303000786 |
News Archive
Frequent bouts of depression, anxiety, hostility and anger are known to increase a person's risk for developing coronary heart disease, but a combination of these "negative" personality traits may put people at especially serious risk, according to a study by researchers at Duke University Medical Center.
The FDA today announced that it will open a public docket to begin receiving public comments on the Institute of Medicine's report on the 510(k) program, the most common pathway to market for lower-risk medical devices.
High-dose chemotherapy and autologous stem cell transplantation, the controversial, arduous, yet once-popular combination treatment that fell out of favor as a therapy for breast cancer, has proven not to be beneficial as an adjuvant therapy for women with node-positive disease, according to an expansive analysis conducted by researchers at The University of Texas M. D. Anderson Cancer Center.
The results of a new study revealed that treatment for women with HER2-positive breast cancer – an aggressive form of the disease which is diagnosed in 10,000 British women each year – slowed the progression of tumors by 40 per cent compared with conventional drugs. Tests on 137 women showed that the new therapy – called T-DM1 – which combines the drug Herceptin with an antibody drug, instead of with standard chemotherapy, appeared to stop the cancer "in its tracks".
Astra Tech, a market leader and innovator in the field of implant dentistry and CAD/CAM abutments, announces a global strategic alliance with 3Shape A/S, the Danish-based provider of 3D scanners and CAD/CAM software solutions.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eduardo J Gonzalez Pons, MD 141 Calle Eufrates, Urbanizacion El Paraiso, San Juan, PR 00926 Ph: (787) 450-8590 | Dr Eduardo J Gonzalez Pons, MD Calle Hernandez Carrion, Manati, PR 00674 Ph: (866) 808-5771 |
News Archive
Frequent bouts of depression, anxiety, hostility and anger are known to increase a person's risk for developing coronary heart disease, but a combination of these "negative" personality traits may put people at especially serious risk, according to a study by researchers at Duke University Medical Center.
The FDA today announced that it will open a public docket to begin receiving public comments on the Institute of Medicine's report on the 510(k) program, the most common pathway to market for lower-risk medical devices.
High-dose chemotherapy and autologous stem cell transplantation, the controversial, arduous, yet once-popular combination treatment that fell out of favor as a therapy for breast cancer, has proven not to be beneficial as an adjuvant therapy for women with node-positive disease, according to an expansive analysis conducted by researchers at The University of Texas M. D. Anderson Cancer Center.
The results of a new study revealed that treatment for women with HER2-positive breast cancer – an aggressive form of the disease which is diagnosed in 10,000 British women each year – slowed the progression of tumors by 40 per cent compared with conventional drugs. Tests on 137 women showed that the new therapy – called T-DM1 – which combines the drug Herceptin with an antibody drug, instead of with standard chemotherapy, appeared to stop the cancer "in its tracks".
Astra Tech, a market leader and innovator in the field of implant dentistry and CAD/CAM abutments, announces a global strategic alliance with 3Shape A/S, the Danish-based provider of 3D scanners and CAD/CAM software solutions.
› Verified 3 days ago
Edgar P Morales-chevres, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Carr #2 Km 47.7, Manati, PR 00674 Phone: 787-621-3322 | |
Mrs. Flora Orama, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: Carr #2 Km 47.7, Barrio Cotto Norte, Manati, PR 00674 Phone: 787-854-3322 Fax: 787-621-3311 | |
Dr. Lorraine Vazquez, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: Carr. #2 Km 47.7, Bo. Cotto Norte, Manati, PR 00674 Phone: 787-884-0389 Fax: 787-621-3311 | |
Dr. Saul Cordero-calero, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: C/marginal Elliot Velez , Esq. Hernandez Urb. Atenas, Centro Radiologico Y Sonografico De Manati, Manati, PR 00674 Phone: 787-854-3131 Fax: 787-854-3235 | |
Dr. Yadira Vazquez Figuer, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Calle Marginal B1, Urb San Salvador, Manati, PR 00674 Phone: 787-854-1818 Fax: 787-854-8524 | |
Lidia I Reyes Nieves, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: Carr #2 Km 47.7, Barrio Cotto Norte, Manati, PR 00674 Phone: 787-621-3322 Fax: 787-621-3311 |